{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:42:54Z","timestamp":1791297774459,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,1,8]],"date-time":"2012-01-08T00:00:00Z","timestamp":1325980800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1038\/nm.2581","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T16:30:20Z","timestamp":1326126620000},"page":"281-285","source":"Crossref","is-referenced-by-count":438,"title":["Identification of the Niemann-Pick C1\u2013like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor"],"prefix":"10.1038","volume":"18","author":[{"suffix":"Jr","given":"Bruno","family":"Sainz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naina","family":"Barretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyelle N","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Hiraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snawar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waddah A","family":"Alrefai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L","family":"Uprichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,8]]},"reference":[{"key":"BFnm2581_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12250-010-3134-0","volume":"25","author":"SL Uprichard","year":"2010","unstructured":"Uprichard, S.L. Hepatitis C virus experimental model systems and antiviral drug research. Virol. Sin. 25, 227\u2013245 (2010).","journal-title":"Virol. Sin."},{"key":"BFnm2581_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00132580-200211000-00011","volume":"4","author":"EK Gupta","year":"2002","unstructured":"Gupta, E.K. & Ito, M.K. Ezetimibe: the first in a novel class of selective cholesterol-absorption inhibitors. Heart Dis. 4, 399\u2013409 (2002).","journal-title":"Heart Dis."},{"key":"BFnm2581_CR3","doi-asserted-by":"publisher","first-page":"8132","DOI":"10.1073\/pnas.0500269102","volume":"102","author":"M Garcia-Calvo","year":"2005","unstructured":"Garcia-Calvo, M. et al. The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proc. Natl. Acad. Sci. USA 102, 8132\u20138137 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2581_CR4","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri, P. et al. Binding of hepatitis C virus to CD81. Science 282, 938\u2013941 (1998).","journal-title":"Science"},{"key":"BFnm2581_CR5","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","volume":"21","author":"E Scarselli","year":"2002","unstructured":"Scarselli, E. et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21, 5017\u20135025 (2002).","journal-title":"EMBO J."},{"key":"BFnm2581_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature05654","volume":"446","author":"MJ Evans","year":"2007","unstructured":"Evans, M.J. et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801\u2013805 (2007).","journal-title":"Nature"},{"key":"BFnm2581_CR7","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nature07684","volume":"457","author":"A Ploss","year":"2009","unstructured":"Ploss, A. et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882\u2013886 (2009).","journal-title":"Nature"},{"key":"BFnm2581_CR8","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1128\/JVI.01888-08","volume":"83","author":"S Liu","year":"2009","unstructured":"Liu, S. et al. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 83, 2011\u20132014 (2009).","journal-title":"J. Virol."},{"key":"BFnm2581_CR9","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1128\/JVI.80.4.1734-1741.2006","volume":"80","author":"DM Tscherne","year":"2006","unstructured":"Tscherne, D.M. et al. Time- and temperature-dependent activation of hepatitis C virus for low-pH\u2013triggered entry. J. Virol. 80, 1734\u20131741 (2006).","journal-title":"J. Virol."},{"key":"BFnm2581_CR10","doi-asserted-by":"publisher","first-page":"11571","DOI":"10.1128\/JVI.01717-06","volume":"80","author":"L Meertens","year":"2006","unstructured":"Meertens, L., Bertaux, C. & Dragic, T. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J. Virol. 80, 11571\u201311578 (2006).","journal-title":"J. Virol."},{"key":"BFnm2581_CR11","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1073\/pnas.0700760104","volume":"104","author":"H Huang","year":"2007","unstructured":"Huang, H. et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. USA 104, 5848\u20135853 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2581_CR12","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1128\/JVI.02053-07","volume":"82","author":"P Gastaminza","year":"2008","unstructured":"Gastaminza, P. et al. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 82, 2120\u20132129 (2008).","journal-title":"J. Virol."},{"key":"BFnm2581_CR13","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1128\/JVI.02530-07","volume":"82","author":"H Aizaki","year":"2008","unstructured":"Aizaki, H. et al. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J. Virol. 82, 5715\u20135724 (2008).","journal-title":"J. Virol."},{"key":"BFnm2581_CR14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1128\/JVI.01134-06","volume":"81","author":"SB Kapadia","year":"2007","unstructured":"Kapadia, S.B., Barth, H., Baumert, T., McKeating, J.A. & Chisari, F.V. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J. Virol. 81, 374\u2013383 (2007).","journal-title":"J. Virol."},{"key":"BFnm2581_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MOL.0b013e3282f9b563","volume":"19","author":"L Yu","year":"2008","unstructured":"Yu, L. The structure and function of Niemann-Pick C1\u2013like 1 protein. Curr. Opin. Lipidol. 19, 263\u2013269 (2008).","journal-title":"Curr. Opin. Lipidol."},{"key":"BFnm2581_CR16","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1126\/science.1093131","volume":"303","author":"SW Altmann","year":"2004","unstructured":"Altmann, S.W. et al. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303, 1201\u20131204 (2004).","journal-title":"Science"},{"key":"BFnm2581_CR17","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1194\/jlr.M600174-JLR200","volume":"47","author":"AT San\u00e9","year":"2006","unstructured":"San\u00e9, A.T. et al. Localization and role of NPC1L1 in cholesterol absorption in human intestine. J. Lipid Res. 47, 2112\u20132120 (2006).","journal-title":"J. Lipid Res."},{"key":"BFnm2581_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1586\/14779072.6.4.447","volume":"6","author":"HE Bays","year":"2008","unstructured":"Bays, H.E., Neff, D., Tomassini, J.E. & Tershakovec, A.M. Ezetimibe: cholesterol lowering and beyond. Expert Rev. Cardiovasc. Ther. 6, 447\u2013470 (2008).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"BFnm2581_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cmet.2008.05.001","volume":"7","author":"TY Chang","year":"2008","unstructured":"Chang, T.Y. & Chang, C. Ezetimibe blocks internalization of the NPC1L1\/cholesterol complex. Cell Metab. 7, 469\u2013471 (2008).","journal-title":"Cell Metab."},{"key":"BFnm2581_CR20","doi-asserted-by":"publisher","first-page":"11140","DOI":"10.1073\/pnas.0800936105","volume":"105","author":"AB Weinglass","year":"2008","unstructured":"Weinglass, A.B. et al. Extracellular loop C of NPC1L1 is important for binding to ezetimibe. Proc. Natl. Acad. Sci. USA 105, 11140\u201311145 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm2581_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/hep.22673","volume":"49","author":"JM Gottwein","year":"2009","unstructured":"Gottwein, J.M. et al. Development and characterization of hepatitis C virus genotype 1\u20137 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49, 364\u2013377 (2009).","journal-title":"Hepatology"},{"key":"BFnm2581_CR22","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1128\/JVI.02356-06","volume":"81","author":"J Grove","year":"2007","unstructured":"Grove, J. et al. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J. Virol. 81, 3162\u20133169 (2007).","journal-title":"J. Virol."},{"key":"BFnm2581_CR23","doi-asserted-by":"publisher","first-page":"e1001131","DOI":"10.1371\/journal.ppat.1001131","volume":"6","author":"E Zaitseva","year":"2010","unstructured":"Zaitseva, E., Yang, S.T., Melikov, K., Pourmal, S. & Chernomordik, L.V. Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog. 6, e1001131 (2010).","journal-title":"PLoS Pathog."},{"key":"BFnm2581_CR24","doi-asserted-by":"publisher","first-page":"e1000702","DOI":"10.1371\/journal.ppat.1000702","volume":"5","author":"KE Coller","year":"2009","unstructured":"Coller, K.E. et al. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog. 5, e1000702 (2009).","journal-title":"PLoS Pathog."},{"key":"BFnm2581_CR25","doi-asserted-by":"publisher","first-page":"25088","DOI":"10.1074\/jbc.M111.244475","volume":"286","author":"JH Zhang","year":"2011","unstructured":"Zhang, J.H. et al. The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake. J. Biol. Chem. 286, 25088\u201325097 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnm2581_CR26","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1099\/vir.0.032391-0","volume":"92","author":"M Yamamoto","year":"2011","unstructured":"Yamamoto, M. et al. Structural requirements of virion-associated cholesterol for infectivity, buoyant density and apolipoprotein association of hepatitis C virus. J. Gen. Virol. 92, 2082\u20132087 (2011).","journal-title":"J. Gen. Virol."},{"key":"BFnm2581_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.1365-2893.2008.01051.x","volume":"15","author":"MJ Farquhar","year":"2008","unstructured":"Farquhar, M.J. & McKeating, J.A. Primary hepatocytes as targets for hepatitis C virus replication. J. Viral Hepat. 15, 849\u2013854 (2008).","journal-title":"J. Viral Hepat."},{"key":"BFnm2581_CR28","doi-asserted-by":"publisher","first-page":"11082","DOI":"10.1128\/JVI.01307-06","volume":"80","author":"J Zhong","year":"2006","unstructured":"Zhong, J. et al. Persistent hepatitis C virus infection in vitro: coevolution of virus and host. J. Virol. 80, 11082\u201311093 (2006).","journal-title":"J. Virol."},{"key":"BFnm2581_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/978-1-59745-394-3_29","volume":"510","author":"NM Kneteman","year":"2009","unstructured":"Kneteman, N.M. & Toso, C. In vivo study of HCV in mice with chimeric human livers. Methods Mol. Biol. 510, 383\u2013399 (2009).","journal-title":"Methods Mol. Biol."},{"key":"BFnm2581_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nm.2341","volume":"17","author":"J Lupberger","year":"2011","unstructured":"Lupberger, J. et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 17, 589\u2013595 (2011).","journal-title":"Nat. Med."},{"key":"BFnm2581_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1517\/17425255.3.3.441","volume":"3","author":"ME Sweeney","year":"2007","unstructured":"Sweeney, M.E. & Johnson, R.R. Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials. Expert Opin. Drug Metab. Toxicol. 3, 441\u2013450 (2007).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"BFnm2581_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/clpt.2009.209","volume":"87","author":"JL Betters","year":"2010","unstructured":"Betters, J.L. & Yu, L. Transporters as drug targets: discovery and development of NPC1L1 inhibitors. Clin. Pharmacol. Ther. 87, 117\u2013121 (2010).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BFnm2581_CR33","doi-asserted-by":"publisher","first-page":"12710","DOI":"10.1074\/jbc.M409110200","volume":"280","author":"JP Davies","year":"2005","unstructured":"Davies, J.P., Scott, C., Oishi, K., Liapis, A. & Ioannou, Y.A. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J. Biol. Chem. 280, 12710\u201312720 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnm2581_CR34","doi-asserted-by":"publisher","first-page":"33586","DOI":"10.1074\/jbc.M405817200","volume":"279","author":"HR Davis Jr.","year":"2004","unstructured":"Davis, H.R. Jr. et al. Niemann-Pick C1 like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J. Biol. Chem. 279, 33586\u201333592 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnm2581_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1053\/j.gastro.2009.04.048","volume":"137","author":"T Matsumura","year":"2009","unstructured":"Matsumura, T. et al. Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry. Gastroenterology 137, 673\u2013681 (2009).","journal-title":"Gastroenterology"},{"key":"BFnm2581_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nm1268","volume":"11","author":"T Wakita","year":"2005","unstructured":"Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791\u2013796 (2005).","journal-title":"Nat. Med."},{"key":"BFnm2581_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.virol.2010.07.026","volume":"407","author":"A Sabahi","year":"2010","unstructured":"Sabahi, A. et al. The rate of hepatitis C virus infection initiation in vitro is directly related to particle density. Virology 407, 110\u2013119 (2010).","journal-title":"Virology"},{"key":"BFnm2581_CR38","first-page":"17.5.1","volume":"18","author":"X Yu","year":"2010","unstructured":"Yu, X. & Uprichard, S.L. Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening. Curr. Protoc. Microbiol. 18, 17.5.1\u201317.5.27 (2010).","journal-title":"Curr. Protoc. Microbiol."},{"key":"BFnm2581_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.cmet.2008.04.001","volume":"7","author":"L Ge","year":"2008","unstructured":"Ge, L. et al. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metab. 7, 508\u2013519 (2008).","journal-title":"Cell Metab."},{"key":"BFnm2581_CR40","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","volume":"165","author":"C Tateno","year":"2004","unstructured":"Tateno, C. et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am. J. Pathol. 165, 901\u2013912 (2004).","journal-title":"Am. J. Pathol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.2581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2581","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.2581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:29:54Z","timestamp":1684448994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.2581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["BFnm2581"],"URL":"https:\/\/doi.org\/10.1038\/nm.2581","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,8]]}}}